RLRebecca P. Lamkin

Rebecca P. Lamkin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rebecca P. Lamkin has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bloodstream Infections Among Veterans With Cardiac Implantable Electronic Devices: Source Identification and Intervention Strategies

    by Dipandita Basnet, Samuel Golenbock, Judith M Strymish, Hillary J Mull, Rebecca P Lamkin, Marlena Shin, Kimberly Harvey, Adolf W Karchmer, Westyn Branch-Elliman

    Bloodstream infection in patients with cardiovascular implantable electronic devices (CIEDs) is not uncommon. Among veterans with CIEDs from 2018 to 2023, 4.7% (1893 of 40 243) developed bacteremia. CIED involvement was identified in 305 patients. Factors associated with increased risk of CIED involvement included known infection of other devices and a diagnosis of endocarditis; urinary tract infection was associated with decreased risk.

  • Open Access

    Development of a feasible and portable electronic flag for near-real-time identification of renal replacement therapy in the Veterans Health Administration

    by Samuel W. Golenbock, Dipandita Basnet, Hillary J. Mull, Rebecca Lamkin, Kimberly Harvey, Marlena Shin, Judith M. Strymish, Sarah Leatherman, Ryan Ferguson, Westyn Branch-Elliman

    Background: Chronic kidney disease (CKD) is prevalent among US Veterans. Identifying patients undergoing dialysis in real-time is crucial for implementing patient safety measures, including stewardship interventions, such as medication dosing adjustments. Limited feasible and accurate tools exist for near-real-time identification. This study aimed to develop a renal replacement therapy (RRT) flag using structured data in the Veterans Health Administration (VHA) electronic health record (EHR). Methods: Data from Veterans who underwent cardiovascular implantable electronic device (CIED) procedures (9/2015–12/2019) were linked to US Renal Data Systems (USRDS) data. Potential identifiers included outpatient hemodialysis procedure records, community care hemodialysis consults, ICD-10 diagnoses, and serum creatinine (SCr) >4 mg/dL. USRDS served as the comparison standard, and sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Logistic regression determined the area under the curve (AUC). Results: Among 37,706 CIED procedures on 34,994 Veterans, 967 patients (2.6%) were identified by USRDS as ever receiving RRT (hemodialysis and peritoneal dialysis or transplant), with 520 (1.4%) actively receiving RRT at the time of CIED. The RRT flag, combining ≥4 outpatient procedures in the prior 30 days, ≥1 consult in the prior year, and/or SCr >4 mg/dL, achieved an AUC of 0.976 (95% CI: 0.97–0.98), with high sensitivity (0.96; 95% CI: 0.94–0.97) and specificity (0.99; 95% CI: 0.99–1.00). The PPV was 0.70 (95% CI: 0.67–0.74). Performance was slightly lower when consults were replaced with ICD codes. Conclusions: We developed an accurate electronic flag using structured data to identify active RRT within VHA among Veterans undergoing invasive procedures, supporting patient safety and care adjustments. This flag addresses a crucial patient safety gap and supports expansion of stewardship efforts.


  • Open Access

    Patient participation disparities of direct-to-patient teledermatology: A retrospective observational study (Preprint)

    by Sara B. Peracca, Daniel J. Sturgeon, Rebecca P. Lamkin, E. David Zepeda, David C. Mohr, Olevie Lachica, Heather A. King, George L. Jackson, Isis J. Morris, Allen L. Gifford, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: While digital technologies have potential to enhance patients’ access to health care, some patients may adopt them better than others. Objective: We identified patient characteristics and usage patterns associated with My VA Images (MVAI), a clinician-gated, patient-facing asynchronous teledermatology mobile application developed by the United States Department of Veterans Affairs (VA) to enable follow-up of established dermatology patients. Methods: MVAI was initially piloted at 3 VA facilities, and then sequentially offered to groups of 7 facilities every 3 months for 1 year. We used VA’s administrative and mobile health databases to examine MVAI usage over a 17-month period. We also collected qualitative data from field notes and interviews with staff. Results: Including 2 pilot facilities, 11 facilities invited 494 dermatology patients to use MVAI during the study period. MVAI invitees were more likely than non-invitees to be White (72% vs. 66%, P=.007), to live in urban areas (30% vs. 25%, P=.02), and to have shorter mean drive times to specialty care (44 vs. 54 minutes, P<.001). MVAI invitees had more total outpatient and dermatology visits before and after MVAI use than the general dermatology outpatient population. 48% of invitees successfully used MVAI. Successful use was highest for follow-up intervals in the 8-30 day range. The mean age of successful users (63) was younger than that of unsuccessful users (68, P<.001). Successful MVAI users were more likely than unsuccessful users to have a dermatology visit one year after MVAI use (median 3 vs. 1, P<.001). Patients requiring multiple attempts to successfully use MVAI were older than initially successful users though younger than unsuccessful users. Patients requiring multiple attempts also had slightly more post-MVAI dermatology visits than initially successful users. Conclusions: Early MVAI usage data indicate that not all patients benefitted equally during the initial rollout of this technological innovation. Non-white and rural patients were under-represented as users, older patients were less successful in using MVAI, and patients who were already relatively high utilizers of health care services were over-represented in the MVAI invitee group. These disparities emphasize the continued need to optimize the equitable distribution of direct-to-patient telehealth’s benefits and suggest specific target groups who may benefit from additional outreach or support. Clinical Trial: ClinicalTrials.gov NCT05128006

  • Open Access

    Operationalizing an adverse event detection surveillance system to support antimicrobial stewardship activities: perceptions and insights from the SHEA research network

    by Hawra J. Al Lawati, Kimberly L. Harvey, Marlena Shin, Hillary Mull, Rebecca P. Lamkin, Samuel Golenbock, Dipandita Basnet-Thapa, Judith M. Strymish, Matthew Lee, Howard Gold, et al.

    A surveillance system for measuring patient-level antimicrobial adverse drug events (ADE) may support stewardship activities, however, design and implementation questions remain. In this national survey, stewardship experts favored simple, laboratory-based ADE definitions although there were tensions between feasibility, ability to identify attribution without chart review, and importance of specific ADE.

  • Open Access

    Factors associated with uptake of guideline-recommended cardiovascular implantable electronic device management: a nationwide, retrospective cohort study

    by Sara Young, Hillary J. Mull, Samuel Golenbock, Kelly Stolzmann, Marlena Shin, Rebecca P. Lamkin, Katherine D. Linsenmeyer, Isabella Epshtein, Emily Kalver, Judith M. Strymish, et al.

    Clinical guidelines recommend device removal for cardiovascular implantable electronic device (CIED) infection management. In this retrospective, nationwide cohort, 60.8% of CIED infections received guideline-concordant care. One-year mortality was higher among those without procedural management (25% vs 16%). Factors associated with receipt of device procedures included pocket infections and positive microbiology.

  • Open Access

    Engaging patients in antimicrobial stewardship: co-designed educational tool to improve periprocedural care through de-implementation of guideline-discordant antimicrobial use

    by Hawra Al Lawati, Marlena Shin, Rebecca Lamkin, Tyler Thompson, Isabella Epshtein, Hillary Mull, Dipandita Basnet Thapa, Dimitri Drekonja, Maria C. Rodriguez-Barradas, Teena Huan Xu, et al.

    Effective de-implementation models often include replacement of an ineffective practice with an alternative. We co-developed patient education materials as a replacement strategy for inappropriate post-procedural antibiotics in cardiac device procedures. Lessons learned and developed materials may be used to promote infection prevention in other periprocedural settings.


  • Arteriovenous Graft Failure in the Veterans Health Administration: Outcome Disparities Associated with Race

    by Mikhail C. S. S. Higgins, Alex Seren, Marva V. Foster, Daniel J. Sturgeon, Nina Bart, Kierstin Hederstedt, Alex Friefeld, Rebecca P. Lamkin, Brian A. Sullivan, Westyn Branch-Elliman, et al.

    Background Vascular access for ongoing hemodialysis often fails, frequently requiring repeated procedures to maintain vascular patency. While research has shown racial discrepancies in multiple aspects of renal failure treatment, there is poor understanding of how these factors might relate to vascular access maintenance procedures after arteriovenous graft (AVG) placement. Purpose To evaluate racial disparities associated with premature vascular access failure after percutaneous access maintenance procedures following AVG placement using a retrospective national cohort from the Veterans Health Administration (VHA). Materials and Methods All hemodialysis vascular maintenance procedures performed at VHA hospitals between October 2016 and March 2020 were identified. To ensure the sample represented patients who consistently used the VHA, patients without AVG placement within 5 years of their first maintenance procedure were excluded. Access failure was defined as a repeat access maintenance procedure or as hemodialysis catheter placement occurring 1-30 days after the index procedure. Multivariable logistic regression analyses were performed to calculate prevalence ratios (PRs) measuring the association between hemodialysis maintenance failure and African American race compared with all other races. Models controlled for vascular access history, patient socioeconomic status, and procedure and facility characteristics. Results In total, 1950 access maintenance procedures in 995 patients (mean age, 69 years ± 9 [SD], 1870 men) with an AVG created in one of 61 VHA facilities were identified. Most procedures involved African American patients (1169 of 1950, 60%) and patients residing in the South (1002 of 1950, 51%). Premature access failure occurred in 215 of 1950 (11%) procedures. When compared with all other races, African American race was associated with premature access site failure (PR, 1.4; 95% CI: 1.07, 1.43; P = .02). Among the 1057 procedures in 30 facilities with interventional radiology resident training programs, there was no evidence of racial disparity in the outcome (PR, 1.1; P = .63). Conclusion African American race was associated with higher risk-adjusted rates of premature arteriovenous graft failure after dialysis maintenance. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Forman and Davis in this issue.